S. Kirschey

Relapsed and/or Refractory Mantle Cell Lymphoma: What Role for Temsirolimus?

G. Hess, S. Kirschey, S. Wagner, 2012, Clinical Medicine Insights. Oncology.

Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma

W. Klapper, C. Buske, M. Dreyling, 2015, Leukemia.

Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B‐cell lymphoma: mature results of a phase II multicentre study

N. Schmitz, M. Gramatzki, H. Wolf, 2015, British journal of haematology.

Successful treatment of Erdheim–Chester disease with combination of interleukin‐1‐targeting drugs and high‐dose glucocorticoids

A. Schwarting, M. Schuchmann, T. Zimmermann, 2014, Internal medicine journal.